Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

43.33
+0.56001.31%
Post-market: 43.400.0745+0.17%17:13 EDT
Volume:2.33M
Turnover:100.87M
Market Cap:103.82B
PE:23.24
High:43.74
Open:43.70
Low:43.02
Close:42.77
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.10
T/O Rate:0.11%
Dividend:2.38
Dividend Rate:5.49%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.30
PE(LYR):11.53

Loading ...

Movement Alert|Sanofi SA Falls 6.38% in Regular Trading, New CEO Raises Guidance but Pipeline Gap Concerns Weigh on Shares

Market Focus
·
Jul 30

Stock Track | Sanofi Plummets 6.56% Intraday as Pipeline Cuts and R&D Uncertainty Overshadow Upgraded Guidance

Stock Track
·
Jul 30

Stock Track | Sanofi Tumbles 5.13% in Pre-Market as Pipeline Cuts and R&D Uncertainty Overshadow Upgraded Guidance

Stock Track
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Movement Alert|Sanofi SA Falls 3.08% in Pre-Market Trading, New CEO Raises Guidance but Pipeline Gaps Weigh on Sentiment

Market Focus
·
Jul 30

New CEO Upgrades Guidance Yet Shares Fall as Sanofi's Pipeline Drought Becomes a Key Weakness

Stock News
·
Jul 30

Sanofi's New CEO Might be Done with Major Portfolio Pruning

Dow Jones
·
Jul 30

Sanofi Might be Better Off Favoring Deals over Internal Drugs

Dow Jones
·
Jul 30

Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study

TIPRANKS
·
Jul 30

Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors

TIPRANKS
·
Jul 30

Movement Alert|Sanofi SA Rises 3.07% in Regular Trading, Pharma Sector Rallies Ahead of Q2 Earnings

Market Focus
·
Jul 28

Sanofi SA Expected to Post Earnings of $1.14 a Share - Earnings Preview

Reuters
·
Jul 28

Sanofi New CEO's Plans Take Spotlight

Dow Jones
·
Jul 28

Top Midday Gainers

MT Newswires Live
·
Jul 25

Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy

TIPRANKS
·
Jul 25

Sanofi Halts Development of Atopic Dermatitis Drug

MT Newswires Live
·
Jul 24

Scribe Therapeutics Prices Upsized IPO at $15 per Share

MT Newswires Live
·
Jul 24

Earning Preview: Sanofi SA this quarter’s revenue is expected to increase by 9.85%, and institutional views are bullish

Earnings Agent
·
Jul 24

Sanofi announces Executive Committee to support next strategic chapter

TIPRANKS
·
Jul 22

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Jul 20